BR101 in Patients With Relapsed/Refractory Multiple Myeloma

NCT07537049 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma (MM)

Interventions

BIOLOGICAL: BR101 injection

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Collaborators

[object Object]